Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease

被引:16
作者
Antipova, Veronica [1 ,2 ]
Holzmann, Carsten [3 ,4 ]
Hawlitschka, Alexander [1 ]
Witt, Martin [1 ,4 ]
Wree, Andreas [1 ,4 ]
机构
[1] Rostock Univ, Inst Anat, Med Ctr, D-18057 Rostock, Germany
[2] Med Univ Graz, Gottfried Schatz Res Ctr Cell Signaling Metab & A, A-8010 Graz, Austria
[3] Rostock Univ, Inst Med Genet, Med Ctr, D-18057 Rostock, Germany
[4] Ctr Transdisciplinary Neurosci Rostock, D-18147 Rostock, Germany
关键词
hemiparkinsonian rat; 6-OHDA; botulinum neurotoxin-A; depression; striatum; behavior; forced swim test; tail suspension test; open field test; elevated plus maze test; correlation analysis; TOXIN TYPE-A; ELEVATED PLUS-MAZE; FORCED SWIMMING TEST; DEPRESSIVE-LIKE BEHAVIORS; MEDIAL FOREBRAIN-BUNDLE; TAIL SUSPENSION TEST; STRIATAL CHOLINERGIC INTERNEURONS; DEEP BRAIN-STIMULATION; ANXIETY-LIKE BEHAVIOR; OPEN-FIELD BEHAVIOR;
D O I
10.3390/toxins13070505
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Parkinson's patients often suffer from depression and anxiety, for which there are no optimal treatments. Hemiparkinsonian (hemi-PD) rats were used to test whether intrastriatal Botulinum neurotoxin-A (BoNT-A) application could also have antidepressant-like properties in addition to the known improvement of motor performance. To quantify depression- and anxiety-like behavior, the forced swim test, tail suspension test, open field test, and elevated plus maze test were applied to hemi-PD rats injected with BoNT-A or vehicle. Furthermore, we correlated the results in the forced swim test, open field test, and elevated plus maze test with the rotational behavior induced by apomorphine and amphetamine. Hemi-PD rats did not show significant anxiety-like behavior as compared with Sham 6-OHDA- + Sham BoNT-A-injected as well as with non-injected rats. However, hemi-PD rats demonstrated increased depression-like behaviors compared with Sham- or non-injected rats; this was seen by increased struggling frequency and increased immobility frequency. Hemi-PD rats intrastriatally injected with BoNT-A exhibited reduced depression-like behavior compared with the respective vehicle-receiving hemi-PD animals. The significant effects of intrastriatally applied BoNT-A seen in the forced swim test are reminiscent of those found after various antidepressant drug therapies. Our data correspond with the efficacy of BoNT-A treatment of glabellar frown lines in treating patients with major depression and suggest that also intrastriatal injected BoNT-A may have some antidepressant-like effect on hemi-PD.
引用
收藏
页数:37
相关论文
共 397 条
[1]   Depression in Parkinson disease-epidemiology, mechanisms and management [J].
Aarsland, Dag ;
Pahlhagen, Sven ;
Ballard, Clive G. ;
Ehrt, Uwe ;
Svenningsson, Per .
NATURE REVIEWS NEUROLOGY, 2012, 8 (01) :35-47
[2]   Heterogeneous neuropathological findings in Parkinson's disease with mild cognitive impairment [J].
Adler, Charles H. ;
Caviness, John N. ;
Sabbagh, Marwan N. ;
Shill, Holly A. ;
Connor, Donald J. ;
Sue, Lucia ;
Evidente, Virgilio G. H. ;
Driver-Dunckley, Erika ;
Beach, Thomas G. .
ACTA NEUROPATHOLOGICA, 2010, 120 (06) :827-828
[3]  
Albanese A, 2003, AM J GASTROENTEROL, V98, P1439
[4]   PARALLEL ORGANIZATION OF FUNCTIONALLY SEGREGATED CIRCUITS LINKING BASAL GANGLIA AND CORTEX [J].
ALEXANDER, GE ;
DELONG, MR ;
STRICK, PL .
ANNUAL REVIEW OF NEUROSCIENCE, 1986, 9 :357-381
[5]   An electrophysiological approach to the diagnosis of neurogenic dysphagia: implications for botulinum toxin treatment [J].
Alfonsi, E. ;
Merlo, I. M. ;
Ponzio, M. ;
Montomoli, C. ;
Tassorelli, C. ;
Biancardi, C. ;
Lozza, A. ;
Martignoni, E. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (01) :54-60
[6]   Depression in Parkinson's disease - Must be properly diagnosis and treated to avoid serious morbidity [J].
Allain, H ;
Schuck, S ;
Mauduit, N .
BRITISH MEDICAL JOURNAL, 2000, 320 (7245) :1287-1288
[7]   Use of antidepressants and the risk of Parkinson's disease: a prospective study [J].
Alonso, A. ;
Garcia Rodriguez, L. A. ;
Logroscino, G. ;
Hernan, M. A. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (06) :671-674
[8]   Botulinum Toxin in Movement Disorders: An Update [J].
Anandan, Charenya ;
Jankovic, Joseph .
TOXINS, 2021, 13 (01)
[9]   OnabotulinumtoxinA Office Treatment for Neurogenic Bladder Incontinence in Parkinson's Disease [J].
Anderson, Rodney U. ;
Orenberg, Elaine K. ;
Glowe, Patricia .
UROLOGY, 2014, 83 (01) :22-27
[10]   Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra [J].
Andringa, G ;
van Oosten, RV ;
Unger, W ;
Hafmans, TGM ;
Veening, J ;
Stoof, JC ;
Cools, AR .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (08) :3033-3043